REGN relationship map
REGN
Regeneron Pharmaceuticals, Inc.
REGNRegeneron Pharmaceuticals, Inc.
100.00% of ACET rev10-K
2°City of Hopeunlisted
2°BX Bodyguard Royaltiesunlisted
2°Rocheunlisted
2°Scitheraunlisted
2°Art Acquisition Subunlisted
2°SparingVision SASunlisted
2°AvenCell Therapeuticsunlisted
2°Alcamiunlisted
BA Leasing BSCunlisted—
Bank of America, N.Aunlisted—
Bayerunlisted—
E. R. Squibb & Sonsunlisted—
Ono Pharmaceuticalunlisted—
Sanofiunlisted—
Santenunlisted—
Sonoma Biotherapeuticsunlisted—
← Buys from
REGNRegeneron Pharmaceuticals, Inc.
Two distributor customersunnamed in filing
77.00% of REGN rev10-K
2°City of Hopeunlisted
2°Ypsomedunlisted
2°GeneQuantum Healthcareunlisted
2°Hangzhou Highlightll Pharmaceuticalunlisted
2°BioArkiveunlisted
2°Aventisunlisted
2°Samsungunlisted
2°Huadongunlisted
2°Genentechunlisted
2°Kyowa Kirinunlisted
2°Undisclosed supplierunnamed in filing
2°KKCunlisted
2°Rocheunlisted
2°United Kingdom governmentunlisted
2°Astellas Pharmaunlisted
2°Maruhounlisted
2°Lonza Salesunlisted
—Bayerunlisted
—Kiniksa Pharmaceuticalsunlisted
—Rocheunlisted
Sells to →
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 15:59 ETSources